Artivion Secures FDA Approval for NEXUS Aortic Arch System

AORT jumps after FDA approves NEXUS Aortic Arch System, unlocking a potential Endospan acquisition and advancing minimally ...

Endospan Receives FDA Approval for the NEXUS(R) Aortic Arch Stent Graft System

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...

FDA approves Endospan’s aortic stent

Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around ...
EurekAlert!

Aortic hemiarch reconstruction safely matches complex aortic arch reconstruction for acute dissection in older adults

NEW ORLEANS—February 1, 2026—Ascending aortic hemiarch reconstruction offers the same long-term benefits to patients over age 65 with acute type A aortic dissection (ATAAD) as more complex extended ...
Morningstar

Endospan Announces Positive One-Year Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System

Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE Investigational Device Exemption (IDE ...
EurekAlert!

Pitt-led research provides insight into development of congenital circulatory defects

PITTSBURGH—University of Pittsburgh-led researchers could provide new insight into how two common congenital circulatory problems—aortic arch deformity and arteriovenous malformations (AVMs)—develop ...